Samuel R Saks Insider Trading $PTGX Protagonist Therapeutics, Inc

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Samuel R Saks.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Samuel R Saks. Samuel R Saks is Director in PDL BIOPHARMA, INC. ($PDLI) and Director in DEPOMED INC ($DMI) and Chief Development Officer in Protagonist Therapeutics, Inc ($PTGX) and Chief Medical Officer in Protagonist Therapeutics, Inc ($PTGX) and Director in Tonix Pharmaceuticals Holding Corp. ($TNXP) and Chief Development Officer in Auspex Pharmaceuticals, Inc. ($ASPX).

Samuel R Saks in Protagonist Therapeutics, Inc

Trading Symbol: PTGX
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Samuel R Saks: Chief Medical Officer, Chief Development Officer
Holdings: 14,000 shares
Current Value: $250,600
Latest Transaction: Feb 26 2021
$PTGX Market Capitalization: $282.80M
$PTGX Previous Close: $17.90

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Samuel R Saks in Protagonist Therapeutics, Inc

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, DMI, ASPX, PDLI, PTGX, TNXP

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Feb 26 2021PTGXProtagonist Therap ...Saks Samuel RChief Medical Offic ...Option ExerciseA23.5790,0002,121,30090,000
Feb 26 2021PTGXProtagonist Therap ...Saks Samuel RChief Medical Offic ...GrantA0.0012,000014,0002 K to 14 K (+600.00 %)
Feb 28 2020PTGXProtagonist Therap ...Saks Samuel RChief Medical Offic ...Option ExerciseA7.8085,000663,00085,000
May 16 2019PTGXProtagonist Therap ...Saks Samuel RChief Medical Offic ...Option ExerciseA10.8045,000486,00045,000
Mar 04 2019PTGXProtagonist Therap ...Saks Samuel RChief Development O ...Option ExerciseA8.0215,000120,30015,000
Mar 04 2019PTGXProtagonist Therap ...Saks Samuel RChief Development O ...GrantA0.002,50002,5000 to 2.5 K
May 31 2018PTGXProtagonist Therap ...Saks Samuel RChief Development O ...Option ExerciseA7.2850,000364,00050,000

Page:   1